{"id":"https://openalex.org/W7166144682","doi":"https://doi.org/10.1248/bpb.b26-00222","title":"An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia","display_name":"An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia","publication_year":2026,"publication_date":"2026-06-26","ids":{"openalex":"https://openalex.org/W7166144682","doi":"https://doi.org/10.1248/bpb.b26-00222","pmid":"https://pubmed.ncbi.nlm.nih.gov/42366104"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.b26-00222","doi":"https://doi.org/10.1248/bpb.b26-00222","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00222","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/6/49_b26-00222/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpb/49/6/49_b26-00222/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035032260","display_name":"Kotaro Sakamoto","orcid":"https://orcid.org/0000-0003-1295-1623","observed_orcids":["https://orcid.org/0000-0003-1295-1623"]},"institutions":[{"id":"https://openalex.org/I4210135245","display_name":"Ichimaru Pharcos (Japan)","ror":"https://ror.org/03dncqh14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210135245"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kotaro Sakamoto","raw_affiliation_strings":["Research & Development Department, Ichimaru Pharcos Co., Ltd., 318\u20131 Asagi, Motosu, Gifu 501\u20130475, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Department, Ichimaru Pharcos Co., Ltd., 318\u20131 Asagi, Motosu, Gifu 501\u20130475, Japan","institution_ids":["https://openalex.org/I4210135245"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zihao Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Zihao Jin","raw_affiliation_strings":["Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061049830","display_name":"Daichi Koan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daichi Koan","raw_affiliation_strings":["Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104129139","display_name":"Runa Fujimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135245","display_name":"Ichimaru Pharcos (Japan)","ror":"https://ror.org/03dncqh14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210135245"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Runa Fujimoto","raw_affiliation_strings":["Research & Development Department, Ichimaru Pharcos Co., Ltd., 318\u20131 Asagi, Motosu, Gifu 501\u20130475, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Department, Ichimaru Pharcos Co., Ltd., 318\u20131 Asagi, Motosu, Gifu 501\u20130475, Japan","institution_ids":["https://openalex.org/I4210135245"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075742112","display_name":"Rei Yokoyama","orcid":"https://orcid.org/0009-0000-7595-4632","observed_orcids":["https://orcid.org/0009-0000-7595-4632"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rei Yokoyama","raw_affiliation_strings":["Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Satoshi Asano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Asano","raw_affiliation_strings":["Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109620373","display_name":"Rika Ishimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rika Ishimura","raw_affiliation_strings":["Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002421342","display_name":"Kazuto Nunomura","orcid":"https://orcid.org/0000-0002-6444-3244","observed_orcids":["https://orcid.org/0000-0002-6444-3244"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuto Nunomura","raw_affiliation_strings":["Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086668054","display_name":"Bangzhong Lin","orcid":"https://orcid.org/0000-0001-5877-949X","observed_orcids":["https://orcid.org/0000-0001-5877-949X"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Bangzhong Lin","raw_affiliation_strings":["Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049354479","display_name":"Daisuke Sugiyama","orcid":"https://orcid.org/0000-0001-6662-368X","observed_orcids":["https://orcid.org/0000-0001-6662-368X"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daisuke Sugiyama","raw_affiliation_strings":["Translational Research Center, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research Center, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033901129","display_name":"Hideki Shiba","orcid":"https://orcid.org/0000-0003-3177-0764","observed_orcids":["https://orcid.org/0000-0003-3177-0764"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Shiba","raw_affiliation_strings":["Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033809239","display_name":"Naoki Nishizawa","orcid":"https://orcid.org/0000-0002-5530-2511","observed_orcids":["https://orcid.org/0000-0002-5530-2511"]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Nishizawa","raw_affiliation_strings":["Chemical Research Laboratories, Nissan Chemical Corporation, 2\u201310\u20131 Tsuboi-Nishi, Funabashi, Chiba 274\u20138507, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Research Laboratories, Nissan Chemical Corporation, 2\u201310\u20131 Tsuboi-Nishi, Funabashi, Chiba 274\u20138507, Japan","institution_ids":["https://openalex.org/I4210112703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108611034","display_name":"Shinsaku Nakagawa","orcid":"https://orcid.org/0000-0001-9500-8889","observed_orcids":["https://orcid.org/0000-0001-9500-8889"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinsaku Nakagawa","raw_affiliation_strings":["Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","Global Center for Medical Engineering and Informatics, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan","Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Supporting Drug Discovery and Life Science Research, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Global Center for Medical Engineering and Informatics, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Osaka, 1\u20136 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5139346032","display_name":"Yukio Ago","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukio Ago","raw_affiliation_strings":["Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","Global Center for Medical Engineering and Informatics, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1\u20132\u20133 Kasumi, Minami-ku, Hiroshima 734\u20138553, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Global Center for Medical Engineering and Informatics, The University of Osaka, 2\u20132 Yamadaoka, Suita, Osaka 565\u20130871, Japan","institution_ids":["https://openalex.org/I98285908"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36025891,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":"6","first_page":"1023","last_page":"1037"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.04729999974370003,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.03929999843239784,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.546999990940094},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9710000157356262},{"id":"https://openalex.org/keywords/lrp1","display_name":"LRP1","score":0.421999990940094},{"id":"https://openalex.org/keywords/peptide-conjugation","display_name":"peptide conjugation","score":0.4740000069141388},{"id":"https://openalex.org/keywords/regioisomers","display_name":"regioisomers","score":0.7139999866485596},{"id":"https://openalex.org/keywords/nanoparticle-stability","display_name":"nanoparticle stability","score":0.5120000243186951},{"id":"https://openalex.org/keywords/novel-object-recognition","display_name":"novel object recognition","score":0.7170000076293945},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6047999858856201},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5817999839782715},{"id":"https://openalex.org/C2984915365","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive impairment","level":3,"score":0.5378999710083008},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5121999979019165},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4828999936580658},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.48260000348091125},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.35179999470710754},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3352999985218048},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.2957000136375427},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.29429998993873596},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.28999999165534973},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.25279998779296875}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051239","descriptor_name":"Receptors, Vasoactive Intestinal Peptide, Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.b26-00222","doi":"https://doi.org/10.1248/bpb.b26-00222","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00222","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/6/49_b26-00222/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:42366104","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42366104","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.b26-00222","doi":"https://doi.org/10.1248/bpb.b26-00222","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b26-00222","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/49/6/49_b26-00222/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G4402423478","display_name":"\u3046\u3064\u75c5\u614b\u306e\u5f62\u6210\u3068\u6cbb\u7642\u306b\u304a\u3051\u308b\u6b63\u8ca0\u306e\u60c5\u52d5\u5236\u5fa1\u795e\u7d4c\u6a5f\u69cb\u306e\u5f79\u5272\u306e\u89e3\u660e","funder_award_id":"25K18713","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G444319226","display_name":null,"funder_award_id":"JP25ama121052","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G4523281972","display_name":null,"funder_award_id":"JP24ama121052","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G4751118171","display_name":null,"funder_award_id":"JP24AMA121054","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G6281743840","display_name":"\u793e\u4f1a\u7684\u884c\u52d5\u7279\u6027\u306b\u57fa\u3065\u304f\u6297\u3046\u3064\u85ac\u53cd\u5fdc\u6027\u306e\u5dee\u7570\u306e\u795e\u7d4c\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u660e","funder_award_id":"24K23296","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G7422307869","display_name":null,"funder_award_id":"JP25ama121054","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166144682.pdf","grobid_xml":"https://content.openalex.org/works/W7166144682.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1593555249","https://openalex.org/W1795981506","https://openalex.org/W1888470382","https://openalex.org/W1963601997","https://openalex.org/W1973333544","https://openalex.org/W1977762520","https://openalex.org/W2018295858","https://openalex.org/W2022825972","https://openalex.org/W2030764613","https://openalex.org/W2099423589","https://openalex.org/W2156825608","https://openalex.org/W2180629755","https://openalex.org/W2541356724","https://openalex.org/W2903548533","https://openalex.org/W3207668063","https://openalex.org/W3214482109","https://openalex.org/W4213284854","https://openalex.org/W4225885267","https://openalex.org/W4234860686","https://openalex.org/W4297369619","https://openalex.org/W4303650256","https://openalex.org/W4313478591","https://openalex.org/W4362587108","https://openalex.org/W4383198858","https://openalex.org/W4389147343","https://openalex.org/W4390619840","https://openalex.org/W4392896354","https://openalex.org/W4399858935","https://openalex.org/W4401264830","https://openalex.org/W4411325414"],"related_works":[],"abstract_inverted_index":{"In":[0,30,99],"2024,":[1],"we":[2,103],"reported":[3],"a":[4,47,58,110,119,129,134,232,236],"brain-penetrant":[5,233],"formulation":[6,145,173,228],"of":[7,28,40,49,87,113,193,201,243],"the":[8,23,37,50,75,100,222,241],"vasoactive":[9],"intestinal":[10],"peptide":[11,16,52],"receptor":[12],"2":[13],"(VIPR2)":[14],"antagonist":[15],"KS-133":[17,33,166,227],"that":[18,61],"mitigated":[19],"cognitive":[20,244],"dysfunction":[21,245],"in":[22,36,161,188,246],"VIPR2":[24,182],"hyperactivation":[25],"mouse":[26],"model":[27],"schizophrenia.":[29,247],"this":[31],"formulation,":[32],"was":[34],"encapsulated":[35],"hydrophobic":[38],"core":[39],"nanoparticles":[41],"(NPs)":[42],"coated":[43,104],"with":[44,107,115,158],"1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-KS-487":[45],"(DPPE-KS-487),":[46],"conjugate":[48,112],"cyclic":[51],"KS-487":[53,114,169],"and":[54,82,91,126,148,178,206],"DPPE":[55],"produced":[56,117],"by":[57],"click":[59,76],"reaction":[60,77],"binds":[62],"low-density":[63],"lipoprotein-related":[64],"protein":[65],"1,":[66],"enabling":[67],"blood-brain":[68],"barrier":[69],"penetration":[70,177],"upon":[71],"subcutaneous":[72],"injection.":[73],"However,":[74],"generated":[78],"multiple":[79],"positional":[80,124],"isomers":[81],"manufacturing":[83,131],"required":[84],"repetitive":[85],"cycles":[86],"ultrasonication":[88,138],"at":[89,139,152,219],"high":[90,140],"low":[92,142],"temperatures,":[93],"posing":[94],"challenges":[95],"for":[96,151,216,240],"industrial":[97],"scalability.":[98],"current":[101],"study,":[102],"KS-133-containing":[105],"NPs":[106],"1,2-distearoyl-sn-glycero-3-phosphoethanolamine-KS-487":[108],"(DSPE-KS-487),":[109],"novel":[111,184],"DSPE":[116],"through":[118],"non-click":[120],"method,":[121],"thus":[122],"eliminating":[123],"isomers,":[125],"also":[127,174],"established":[128],"simplified":[130],"process":[132],"allowing":[133],"unidirectional":[135],"transition":[136],"from":[137],"to":[141,191,214],"temperatures.":[143],"This":[144,225],"remained":[146],"physically":[147],"chemically":[149],"stable":[150],"least":[153],"12":[154],"months":[155],"under":[156],"refrigeration,":[157],"no":[159,197],"changes":[160],"particle":[162],"size,":[163],"zeta":[164],"potential,":[165],"content,":[167],"or":[168],"presentation":[170],"level.":[171],"The":[172],"exhibited":[175],"brain":[176],"therapeutic":[179],"efficacy":[180],"against":[181],"agonist-induced":[183],"object":[185],"recognition":[186],"impairment":[187],"mice":[189,215],"comparable":[190],"those":[192],"DPPE-KS-487":[194],"NPs.":[195],"Furthermore,":[196],"systemic":[198],"side":[199],"effects":[200],"hematologic,":[202],"brain,":[203],"heart,":[204],"liver,":[205],"lung":[207],"toxicity":[208],"were":[209],"detected":[210],"following":[211],"daily":[212],"injections":[213],"two":[217],"weeks":[218],"five":[220],"times":[221],"effective":[223],"dose.":[224],"new":[226],"incorporating":[229],"DSPE-KS-487":[230],"as":[231],"shuttle":[234],"is":[235],"promising":[237],"drug":[238],"candidate":[239],"treatment":[242]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2026-06-27T00:00:00"}